GPT and metabolic dysfunction-associated steatotic liver disease: Furthermore, after adjusting for confounders according to the final model (based on model 1 + hip circumference, education, drug use, disease history, FBS, ALT, AST, Lipid profiles, and energy intake), higher scores of adherence to the OBS conferred a protection for the presence of NAFLD (OR: 0.29; 95% CI 0.15–0.49; P for trend < 0.001).